Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2012 Aug 20;11(11):2541–2546. doi: 10.1158/1535-7163.MCT-12-0358

Figure 1. CT scan of the chest of the patient with chondrosarcoma showing lung metastasis of chondrosarcoma.

Figure 1

A: Before Apo2L/TRAIL therapy

B: Three years after Apo2L/TRAIL. The patient achieved a sustained partial response and ultimately a complete response by RECIST.

C and E: Image showing resistant tumor that emerged during Apo2L/TRAIL therapy before surgical resection

D and F: Image showing scan after 75 months after Apo2L/TRAIL therapy demonstrating a complete response